This article has been updated from a previous version to include information about the company's listing transfer.
 
NEW YORK (GenomeWeb News) – In a move to reduce costs, Nanogen said Thursday that it plans to transfer its Toronto, Canada, point-of-care manufacturing operations to its San Diego facility and to cease all manufacturing operations in Canada by the end of the year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.